Sonia Hallen

Investment Manager

2024 - Current

Focused on Gilde’s private therapeutics strategy in the Venture & Growth team. Gilde Healthcare is a specialized healthcare investor managing over €2.6 billion across two fund strategies: Venture&Growth and Private Equity. Sonia is dedicated to the Venture&Growth fund of Gilde Healthcare, which invests in fast growing companies active in therapeutics, medtech and digital health, based in Europe and North America.

Founder and Board Member

2018

A unique medicines company that uses Artificial Intelligence to tailor therapies for unique patients.

Vice President

2022 - 2024

Board Member

2021 - 2024

Board Observer

2021 - 2024

Board Observer

2022 - 2023

Associate

2019 - 2022

One of Europe's largest and most experienced Life Sciences investment firms. Venture Capitalist focused on unlisted companies developing innovative therapeutics, medical devices, diagnostics and digital health platforms.

Consultant - Life Sciences

2016 - 2018

Helped companies rethink, reshape or restructure businesses to deliver better patient outcomes and drive shareholder returns.

Stem Cell Therapies Scientist

2012 - 2016

Developed biomaterial-based regenerative therapies for treatment of cardiac diseases.

Founder & CEO

2014 - 2015

Early stage start-up developing smart point-of-care solutions to treat and diagnose infectious diseases.